The bioinformatics cloud platform market is a subset of the larger cloud computing market that focuses on providing computational resources and analytical tools for bioinformatics applications. Bioinformatics is a multidisciplinary field that combines biology, computer science, statistics, and mathematics to analyze biological data. Bioinformatics cloud platforms offer a cost-effective and scalable solution for processing and analyzing large volumes of biological data, such as DNA sequencing data, proteomic data, and transcriptomic data.
Cloud-based bioinformatics platforms offer a number of services, such as data processing, data analysis, and visualization. In order to find patterns and correlations in biological data that may be used to inform decisions about drug discovery and development, personalized medicine, and precision medicine, these platforms employ cutting-edge algorithms and machine learning approaches. Due to the rising need for bioinformatics applications across a number of industries, including pharmaceuticals, biotechnology, healthcare, and academic research, the market for bioinformatics cloud platforms is anticipated to expand.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion) |
| Segmentation | By Deployment Model, By Service Models, By, Applications, By End-User By Region |
| By Deployment Model |
|
| By Service Model |
|
| By Applications |
|
| By End-user |
|
| By Region |
|
The requirement for effective and affordable data management solutions, the expanding popularity of precision medicine, and the demand for personalized medicine are some of the drivers driving the market for bioinformatics cloud platforms. Researchers now have the option to securely and scalable handle, store, and analyses massive amounts of data thanks to bioinformatics cloud platforms. The entire cost of data administration and analysis is decreased by the adoption of cloud-based solutions, which also do away with the requirement for costly on-premises infrastructure.
Another major driver for the bioinformatics cloud platform market is the growing demand for personalized medicine. The use of bioinformatics cloud platforms has enabled researchers to analyze vast amounts of genetic and clinical data to develop personalized treatments for patients. With the increasing availability of genomic data, there is a growing need for efficient and accurate analysis of this data to provide personalized treatment options. Bioinformatics cloud platforms provide a cost-effective and scalable solution for the storage, management, and analysis of genomic data, enabling researchers and clinicians to develop targeted treatments for patients.
The absence of standardized data formats and quality can make data integration and analysis challenging, which is one of the major barriers to the market for bioinformatics cloud platforms. The adoption of cloud-based solutions in some companies may also be constrained by worries about data security and privacy, notably in the healthcare sector. Finally, certain businesses may find it difficult to use bioinformatics cloud platforms due to their expensive implementation and maintenance costs.
The COVID-19 pandemic had a favorable effect on the market for bioinformatics cloud platforms since it enhanced demand for virtual and remote research solutions. The pandemic brought to light the value of bioinformatics and data analysis in the search for new drugs and vaccines. Researchers and organizations hurried to find solutions for remote work and collaborations, which resulted in an increase in demand for cloud-based bioinformatics tools and services. The pandemic has sped up the use of cloud-based bioinformatics systems and is predicted to keep driving industry expansion.
The bioinformatics cloud platform market is expected to grow at 13.2% CAGR from 2022 to 2029. It is expected to reach above USD 7.39 billion by 2029 from USD 2.42 billion in 2020.
North America share 36 % of the total market size of bioinformatics cloud platform market.
The requirement for effective and affordable data management solutions, the expanding popularity of precision medicine, and the demand for personalized medicine are some of the drivers driving the market for bioinformatics cloud platforms. Researchers now have the option to securely and scalable handle, store, and analyses massive amounts of data thanks to bioinformatics cloud platforms. The entire cost of data administration and analysis is decreased by the adoption of cloud-based solutions, which also do away with the requirement for costly on-premises infrastructure.
Key companies in the global market Amazon Web Services, Google, Microsoft Azure, IBM Corporation, Oracle Corporation, Dassault Systems SA, Illumina Inc, Qiagen V, Thermo Fisher Scientific Inc, DNA nexus Inc, Seven Bridges Genomics Inc.
In terms of deployment model, the deployment model segment includes public, private, and hybrid cloud. Public cloud platforms are offered by third-party providers and can be accessed by anyone with an internet connection. Private clouds, on the other hand, are dedicated to a single organization and are not shared with others. Hybrid clouds combine both public and private cloud infrastructure to provide a more flexible solution.
The enterprise file sync and share market is segmented based on deployment model, service model, applications, end-user and region.
In terms of deployment model, the deployment model segment includes public, private, and hybrid cloud. Public cloud platforms are offered by third-party providers and can be accessed by anyone with an internet connection. Private clouds, on the other hand, are dedicated to a single organization and are not shared with others. Hybrid clouds combine both public and private cloud infrastructure to provide a more flexible solution.
Based on service model, the service model segment includes software as a service (SaaS), platform as a service (PaaS), and infrastructure as a service (IaaS). SaaS is a complete software solution that is delivered over the internet. PaaS provides a platform for developers to build, test, and deploy applications. IaaS provides virtualized computing resources such as servers, storage, and networking.
Based on end-user, the end-user segment includes academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and others. Academic and research institutes use bioinformatics cloud platforms for research and development purposes. Pharmaceutical and biotechnology companies use bioinformatics cloud platforms for drug discovery and development. Contract research organizations provide research services to pharmaceutical and biotechnology companies.
[caption id="attachment_24468" align="aligncenter" width="1920"]
Key companies in the global market Amazon Web Services, Google, Microsoft Azure, IBM Corporation, Oracle Corporation, Dassault Systems SA, Illumina Inc, Qiagen V, Thermo Fisher Scientific Inc, DNA nexus Inc, Seven Bridges Genomics Inc.
Recent Developments 16-05-2021: - Oxford University and Oracle Partner to Speed Identification of COVID-19 Variants. The partnership will enable global genomic sequencing and examination through a specialist platform developed on Oracle Cloud Infrastructure to help mitigate the impact of potentially dangerous COVID-19 variants 5-06-2021: - IBM and Francisco Partners announced a definitive agreement under which Francisco Partners acquired health data and analytics assets from IBM that were part of the Watson Health business.The Bioinformatics Cloud Platform market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
North America holds 36% of the total market share in bioinformatics. Due to the presence of well-established pharmaceutical and biotech companies, rising investments in R&D activities, and supportive government initiatives, North America is the region with the greatest market for bioinformatics cloud platforms. The region has seen a sharp growth in the need for precision and personalized medicine, which has resulted in a surge in the use of bioinformatics cloud platforms. Thermo Fisher Scientific Inc., IBM Corporation, Illumina Inc., and other leading companies are active in the North American market. In the upcoming years, it is anticipated that this region will continue to grow.
The growing demand for bioinformatics in drug discovery and development, notably in China and India, is anticipated to propel the Asia-Pacific bioinformatics cloud platform market to considerable growth in the next years. The growing popularity of precision medicine and personalized treatment in the area is also anticipated to fuel market growth.
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.